← All medicines

Neurological medicines

Memantine

Independent educational summary · Sources checked November 20, 2026

An NMDA-receptor medicine for specified Alzheimer symptoms; it does not cure the disease.

Profile scope: Memantine. Confirm the exact product and route; formulations and combination products are not interchangeable.

Possible side effects

Dizziness, confusion, headache, sleepiness, bowel changes, or mood and behavior changes may occur.

Serious risks and warning signs

New hallucinations or breathlessness requires prompt assessment. Significant changes in alertness, balance, or behavior deserve review rather than being automatically attributed to dementia. Kidney function and other medicines affect dosing and tolerability.

A question for your healthcare team

How will kidney function, falls, cognition, and behavior be reviewed, and which changes should caregivers report urgently?

What to do with this information

Discuss persistent or troubling symptoms with your prescriber or pharmacist. For severe breathing difficulty, collapse, a seizure, or inability to wake someone, seek emergency help. Read the linked medicine information for drug-specific instructions, including situations requiring immediate action. For routine treatment changes, consult your prescriber rather than changing your dose on your own. Follow the urgent action instructions above and in the linked medicine information.

Sources

Sources checked November 20, 2026. An original AI-assisted educational summary, not a complete adverse-effect or interaction list. This profile is part of the broader library expansion, not the original prescription-use ranking. Inclusion does not confirm current product availability or mean that risks outweigh benefits. This page has not been independently reviewed by a clinician.